Form 4 for TNXP Tonix Pharmaceuticals Holding Corp.
Accepted 2025-05-15 00:00:00 ET · period of report 2025-05-15 · accession 0001999371-25-006261 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-05-15 | 2025-05-15 | TNXP | LEDERMAN SETH | CEO, Dir | P - Purchase | $21.55 | +4,000 | 4,005 | +80,000% | +$86.2K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock, $0.001 par value | 2025-05-15 | P | A | 4,000 | $21.55 | 4,005 | D | — | — |